Johnson Matthey PLC (LON:JMAT - Get Free Report) passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 2,107.70 and traded as high as GBX 2,120. Johnson Matthey shares last traded at GBX 2,094.32, with a volume of 38,347,059 shares changing hands.
Wall Street Analyst Weigh In
JMAT has been the topic of several research analyst reports. Berenberg Bank dropped their target price on shares of Johnson Matthey from GBX 2,250 to GBX 2,100 and set a "buy" rating on the stock in a research report on Monday, March 23rd. Deutsche Bank Aktiengesellschaft raised their price objective on Johnson Matthey from GBX 1,922 to GBX 2,120 and gave the company a "buy" rating in a report on Tuesday, April 7th. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. According to data from MarketBeat, Johnson Matthey currently has a consensus rating of "Moderate Buy" and a consensus price target of GBX 2,222.
Check Out Our Latest Report on Johnson Matthey
Johnson Matthey Stock Up 0.8%
The company has a current ratio of 1.65, a quick ratio of 0.76 and a debt-to-equity ratio of 71.01. The company has a market capitalization of £3.51 billion, a price-to-earnings ratio of -31.78, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.90. The firm's fifty day simple moving average is GBX 1,967.03 and its two-hundred day simple moving average is GBX 2,107.70.
Insider Buying and Selling at Johnson Matthey
In other news, insider Andrew Cosslett bought 5,136 shares of the firm's stock in a transaction on Tuesday, February 24th. The shares were bought at an average cost of GBX 1,937 per share, for a total transaction of £99,484.32. Also, insider Alastair Judge bought 14 shares of the firm's stock in a transaction on Wednesday, April 15th. The stock was purchased at an average price of GBX 2,022 per share, for a total transaction of £283.08. Insiders have bought 10,434 shares of company stock worth $20,147,908 in the last ninety days. 0.51% of the stock is owned by insiders.
About Johnson Matthey
(
Get Free Report)
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers' products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet's natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Johnson Matthey, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Johnson Matthey wasn't on the list.
While Johnson Matthey currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
